-
Goldman Sachs Reiterates Sell on AMLN and Neutral on ALKS
Friday, July 8, 2011 - 9:24am | 35Goldman Sachs reiterated its Sell rating on Amylin Pharmaceuticals (NASDAQ: AMLN) and its Neutral rating on Alkermes (NASDAQ: ALKS).
-
Deutsche Bank Maintains Hold Rating On Amylin
Friday, July 8, 2011 - 9:20am | 65According to Deutsche Bank, Amylin Pharmaceuticals (NASDAQ: AMLN) Hold rating is maintained. Deutsche Bank said that Amylin just announced that the FDA-required tQT study demonstrated that exenatide at and above therapeutic levels did not prolong QTc interval in healthy volunteers. “We currently...
-
Baxter and Halozyme Announce Top-Line Results of Phase III Study of HyQ in Patients with Primary Immunodeficiency
Friday, July 8, 2011 - 8:39am | 98Baxter International Inc. (NYSE: BAX) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced top-line results of a phase III study of HyQ, an investigational facilitated subcutaneous immune globulin product for use in patients with primary immunodeficiency . The subcutaneous...
-
Jefferies Maintains Buy on Amylin Pharmaceuticals
Friday, July 8, 2011 - 8:34am | 85Jefferies is out with its report today on Amylin Pharmaceuticals (NASDAQ: AMLN), maintaining Buy. In a note to clients, Jefferies writes, "Today, AMLN reported that the Bydureon thorough QT (tQT) study did not show prolongation of the QT interval. We believe this positive outcome, which is in line...
-
Hearing Leerink Swan Positive on Bio Sante, $6 Target Price
Friday, July 8, 2011 - 8:20am | 31@markflowchatter reports that Leerink Swan has released another positive report on Bio Sante (NASDAQ: BPAX).
-
Benzinga's Top Pre-Market NASDAQ Gainers
Friday, July 8, 2011 - 8:18am | 119Amylin Pharmaceuticals Inc (NASDAQ: AMLN) shares advanced 9.41% to $15 in the pre-market session. Alkermes Inc (NASDAQ: ALKS) and AMLN reported positive data on their Bydureon drug. Geron Corporation (NASDAQ: GERN) shares advanced 8.75% to $4.35 in the pre-market session. GERN had $163.33 million...
-
Hottest and Coldest Sectors for Thursday 7/7/2011
Thursday, July 7, 2011 - 7:35pm | 1705The S&P 500 (SPX) gained 14 points, or 1%, in today's session to close at 1353.22. The index is nearing its 52-week high of 1370.58, which was set on May 2nd. The Sector breakdown for Thursday's session is as follows: The S&P 500 was led by the Basic Materials Sector in Thursday's session...
-
YM BioSciences Files Preliminary Base Shelf Prospectus
Thursday, July 7, 2011 - 5:01pm | 225YM BioSciences Inc. (NYSE: YMI) today announced it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada and a registration statement on Form F-10 with the United States Securities and Exchange Commission. Once the shelf prospectus is cleared...
-
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering of Common Stock and Warrants
Thursday, July 7, 2011 - 4:02pm | 164Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today announced that it has closed its previously announced underwritten offering of an aggregate of 7,617,646 units at an offering price of $1.36 per unit for gross proceeds of $10.36 million. Each unit consists of (i) one share of...
-
Catalysts Abound For Regeneron Pharmaceuticals
Thursday, July 7, 2011 - 2:57pm | 491Regeneron Pharmaceuticals (NASDAQ: REGN) is a $5.54 billion biopharmaceutical firm with one marketed product and numerous late-stage drugs in its pipeline with several FDA approval filings scheduled for the second half of 2011. In addition, REGN has an early to mid-stage human monoclonal antibody...
-
High-Flying Breakout Plays for 7/7
Thursday, July 7, 2011 - 12:12pm | 83Half of the trading day is already gone, but here are the setups that I like the most heading in the afternoon of trading. All seven plays are very strong, but on two of them, you will want to make sure volume picks up with the breakout. I actually got in BWS already this morning. Read more...
-
Celsion Racing Toward Daily Highs
Thursday, July 7, 2011 - 10:39am | 99Shares of Celsion Corporation (NASDAQ: CLSN) are trading higher on the session by 4.72%, trading at $3.49. The stock posted a strong rally this morning and has been consolidating above the 50-minute moving average ever since. Shares are now finding buyers, who are taking down stock on the offer....
-
Benzinga's Top Pre-Market NASDAQ Gainers
Thursday, July 7, 2011 - 8:21am | 131Nova Measuring Instruments Ltd (NASDAQ: NVMI) shares advanced 3.32% to $10.88 in the pre-market session. NVMI received multiple orders from leading edge customers for its newest Integrated Metrology system - the Nova i500. Urban Outfitters Inc (NASDAQ: URBN) shares advanced 3.09% to $31.70 in the...
-
Synta Announces Presentation of Ganetespib Phase 2 Non-small Cell Lung Cancer Trial Results
Thursday, July 7, 2011 - 8:07am | 97Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today presented results at the International Association for the Study of Lung Cancer 14th World Conference on Lung Cancer from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer that showed promising clinical...
-
Idera Pharmaceuticals Provides Update on IMO-2055 Clinical Development Program
Thursday, July 7, 2011 - 7:48am | 148Idera Pharmaceuticals (NASDAQ: IDRA) today provides an update on the clinical development of IMO-2055, a TLR9 agonist for cancer treatment being developed by Merck KGaA, Darmstadt, Germany, under its collaboration with Idera. Merck KGaA has informed Idera that, based on increased incidence of...